罗马尼亚Cryptosporidium感染的流行病学:一篇综述
Gheorghe Dărăbuș1, Maria Alina Lupu2,3, Narcisa Mederle1
1Discipline of Parasitology, Faculty of Veterinary Medicine, University of Life Sciences King Michael I, 300645 Timisoara, Romania.
在罗马尼亚,Cryptosporidium感染发生在健康和免疫受损的个体中. 这篇评论强调了寄生虫.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 人类医学 人类医学 医学
- 流行病学 流行病学
背景情况:
- 克里普托斯波里迪亚 spp. 在罗马尼亚,1983年首次报告感染.
- 大多数罗马尼亚研究在国际上无法获得.
- 密码化症通常与免疫力低下的个体和低收入国家有关.
研究的目的:
- 审查Cryptosporidium spp.的流行病学情况. 在罗马尼亚.
- 为了突出免疫能力强的个体感染的发生情况.
- 为国家预防战略提供基础.
主要方法:
- 对罗马尼亚关于Cryptosporidium spp.的研究进行文献综述.
主要成果:
- 在健康儿童中患病率:9.1%.
- 免疫功能低下儿童的患病率:73%.
- 在免疫功能低下的成年人中流行率:1.850%.
- 动物的流行:牛 (28.52%),水牛犊 (18%),猪 (27.860.4%),狗 (52.7%),猫 (29.4%).
结论:
- 克里普托斯波里迪亚 spp. 在罗马尼亚,感染发生在各种人群中,包括健康人群.
- 动物水库非常重要.
- 罗马尼亚的密码菌病的总体负担仍然是未知的.
更多相关视频
07:56Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
Published on: June 10, 2022
12:11A Modified EPA Method 1623 that Uses Tangential Flow Hollow-fiber Ultrafiltration and Heat Dissociation Steps to Detect Waterborne Cryptosporidium and Giardia spp.
Published on: July 9, 2012
相关概念视频
Fungal Phylum Microsporidia
Urinary Tract Infection II: Pathophysiology
Diversity of Protists I
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
